Bioxcel Therapeutics Inc.(BTAI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BTAI Bioxcel Therapeutics Inc.

已收盘 04-14 16:00:00 EDT

1.06

+0.04

+3.92%

盘后1.05

-0.01-1.10%

19:56 EDT

最高1.08	最低1.01	成交量76.99万
今开1.01	昨收1.02	日振幅6.86%
总市值2,870万	流通市值2,615万	总股本2,707万
成交额81.23万	换手率3.12%	流通股本2,467万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BTAI","market":"US","secType":"STK","nameCN":"Bioxcel Therapeutics Inc.","latestPrice":1.06,"timestamp":1776196800000,"preClose":1.02,"halted":0,"volume":769891,"hourTrading":{"tag":"盘后","latestPrice":1.0483,"preClose":1.06,"latestTime":"19:56 EDT","volume":4314,"amount":4554.1063,"timestamp":1776210997703,"change":-0.0117,"changeRate":-0.011038,"amplitude":0.020472},"delay":0,"changeRate":0.03921568627450984,"floatShares":24672100,"shares":27074586,"eps":-5.73,"marketStatus":"已收盘","change":0.04,"latestTime":"04-14 16:00:00 EDT","open":1.01,"high":1.08,"low":1.01,"amount":812274.3464301,"amplitude":0.068627,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.73,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1776240000000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1520485200000,"exchange":"NASDAQ","adjPreClose":1.02,"preHourTrading":{"tag":"盘前","latestPrice":1.0399,"preClose":1.02,"latestTime":"09:22 EDT","volume":12608,"amount":12954.5472704,"timestamp":1776172930402,"change":0.0199,"changeRate":0.01951,"amplitude":0.019608},"postHourTrading":{"tag":"盘后","latestPrice":1.0483,"preClose":1.06,"latestTime":"19:56 EDT","volume":4314,"amount":4554.1063,"timestamp":1776210997703,"change":-0.0117,"changeRate":-0.011038,"amplitude":0.020472},"volumeRatio":0.664141,"impliedVol":0.2625,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/BTAI","defaultTab":"news","newsList":[{"id":"1161815906","title":"BioXcel Therapeutics Inc：FDA为Igalmi新药申请设定PDUFA目标审评日期为2026年11月14日——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1161815906","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161815906?lang=zh_cn&edition=full","pubTime":"2026-04-01 19:00","pubTimestamp":1775041218,"startTime":"0","endTime":"0","summary":"根据一份提交给美国证券交易委员会（SEC）的文件披露，BioXcel Therapeutics Inc. 已获得美国食品药品监督管理局（FDA）就其Igalmi新药申请设定的处方药使用者付费法案（PDUFA）目标审评日期。该关键日期定于2026年11月14日，标志着监管机构完成审评的最后期限。\n这一进展为该公司针对Igalmi的审批路径提供了明确的时间表，是药物研发过程中的一个重要监管里程碑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BTAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176205883","title":"BioXcel Therapeutics宣布FDA受理Igalmi®居家使用补充新药申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1176205883","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176205883?lang=zh_cn&edition=full","pubTime":"2026-04-01 19:00","pubTimestamp":1775041216,"startTime":"0","endTime":"0","summary":"BioXcel Therapeutics Inc. (BTAI) 近日宣布，美国食品药品监督管理局（FDA）已正式受理其旗下药物Igalmi®用于居家环境的补充新药申请（sNDA）。这一进展标志着该药物在拓展临床应用场景方面迈出重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186310919","title":"BioXcel Therapeutics股价盘前飙升21.1%，实验性阿片类药物戒断疗法中期试验显效","url":"https://stock-news.laohu8.com/highlight/detail?id=1186310919","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186310919?lang=zh_cn&edition=full","pubTime":"2026-03-05 20:35","pubTimestamp":1772714114,"startTime":"0","endTime":"0","summary":"BioXcel Therapeutics Inc. (BTAI) 股价在盘前交易中大幅上涨21.1%，此前该公司宣布其用于治疗阿片类药物戒断的实验性药物在一项中期临床试验中显示出积极疗效。这一积极数据显著提振了投资者信心，推动该公司股价强势上扬。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115086186","title":"BioXcel Therapeutics Inc.：Bxcl501在治疗阿片类药物戒断症状中展现出临床获益与良好耐受性","url":"https://stock-news.laohu8.com/highlight/detail?id=1115086186","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115086186?lang=zh_cn&edition=full","pubTime":"2026-03-05 20:10","pubTimestamp":1772712603,"startTime":"0","endTime":"0","summary":"BioXcel Therapeutics Inc.公布的最新临床数据显示，其研究性药物Bxcl501在治疗阿片类药物戒断症状方面表现出显著的临床益处和良好的耐受性特征。该结果突显了该疗法在应对这一严峻公共卫生挑战方面的潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BTAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145611771","title":"BioXcel Therapeutics公布哥伦比亚大学主导的Bxcl501治疗阿片戒断二期研究积极顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1145611771","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145611771?lang=zh_cn&edition=full","pubTime":"2026-03-05 20:04","pubTimestamp":1772712277,"startTime":"0","endTime":"0","summary":"BioXcel Therapeutics宣布，由哥伦比亚大学主导的Bxcl501用于治疗阿片戒断的二期临床研究取得积极顶线结果。该研究达到了主要终点，显示Bxcl501能显著缓解戒断症状。公司计划基于这些数据与监管机构讨论后续开发路径。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607040825","title":"Bioxcel Therapeutics, Inc.盘中异动 早盘股价大跌5.55%报1.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607040825","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607040825?lang=zh_cn&edition=full","pubTime":"2026-01-31 00:05","pubTimestamp":1769789135,"startTime":"0","endTime":"0","summary":"北京时间2026年01月31日00时05分，Bioxcel Therapeutics, Inc.股票出现波动，股价快速下挫5.55%。截至发稿，该股报1.53美元/股，成交量24.6911万股，换手率1.13%，振幅4.94%。Bioxcel Therapeutics, Inc.股票所在的制药行业中，整体跌幅为0.08%。其相关个股中，Cbdmd, Inc.、Caring Brands, Inc.、惠普森医药涨幅较大，Cbdmd, Inc.、苏轩堂、Akanda Corp.较为活跃，换手率分别为43.64%、23.03%、7.59%，振幅较大的相关个股有Cbdmd, Inc.、苏轩堂、坎伯兰药业，振幅分别为46.20%、14.80%、10.54%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260131000536a469f242&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260131000536a469f242&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BTAI","LENZ","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130828482","title":"BioXcel Therapeutics公司：Igalmi适应症扩展提交时间表支持其最早于2026年底前获得潜在批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1130828482","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130828482?lang=zh_cn&edition=full","pubTime":"2026-01-20 20:09","pubTimestamp":1768910960,"startTime":"0","endTime":"0","summary":"BioXcel Therapeutics公司近期公布的提交时间表显示，其药物Igalmi的适应症扩展申请有望最早在2026年底前获得监管批准。这一时间规划为该公司核心产品的市场拓展提供了明确的路线图。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107487940","title":"BioXcel Therapeutics向FDA提交Igalmi®补充新药申请 寻求拓展家用适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=1107487940","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107487940?lang=zh_cn&edition=full","pubTime":"2026-01-20 20:07","pubTimestamp":1768910863,"startTime":"0","endTime":"0","summary":"BioXcel Therapeutics公司已向美国食品药品监督管理局提交了Igalmi®的补充新药申请。此次申请旨在扩大该药物的标签适应症范围，将其使用场景延伸至家庭环境。这一举措若获批准，将有望为患者在居家场景下管理相关症状提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BTAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126861272","title":"BioXcel Therapeutics计划本月提交补充新药申请 寻求FDA批准Igalmi®居家使用","url":"https://stock-news.laohu8.com/highlight/detail?id=1126861272","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126861272?lang=zh_cn&edition=full","pubTime":"2026-01-07 20:02","pubTimestamp":1767787357,"startTime":"0","endTime":"0","summary":"BioXcel Therapeutics Inc. (BTAI) 正积极推进其药物Igalmi®的适用范围扩展。公司计划于本月内向美国食品药品监督管理局(FDA)提交补充新药申请(sNDA)，核心目标是寻求批准该药物可用于居家环境。\n此举若获成功，将标志着Igalmi®在应用场景上的重要突破，为患者提供更便捷的治疗选择。目前，该申请的具体细节和预期时间表备受市场关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BTAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588169089","title":"Bioxcel Therapeutics, Inc.盘中异动 早盘股价大跌5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588169089","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588169089?lang=zh_cn&edition=full","pubTime":"2025-12-01 22:30","pubTimestamp":1764599453,"startTime":"0","endTime":"0","summary":"北京时间2025年12月01日22时30分，Bioxcel Therapeutics, Inc.股票出现波动，股价大幅下跌5.25%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Q32 Bio Inc.、Kala Bio, Inc.、Dyadic International, Inc.涨幅较大，Kala Bio, Inc.、Q32 Bio Inc.、Aditxt, Inc.较为活跃，换手率分别为475.90%、465.01%、46.44%，振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Kala Bio, Inc.、Quantum Biopharma Ltd.，振幅分别为92.88%、12.42%、10.10%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512012230549524da5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512012230549524da5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BTAI","LENZ","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127180056","title":"BioXcel Therapeutics发布2025年第三季度财报并更新双相情感障碍、精神分裂症和阿尔茨海默病的晚期临床项目进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1127180056","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127180056?lang=zh_cn&edition=full","pubTime":"2025-11-12 20:01","pubTimestamp":1762948881,"startTime":"0","endTime":"0","summary":"BioXcel Therapeutics发布2025年第三季度财报并更新双相情感障碍、精神分裂症和阿尔茨海默病的晚期临床项目进展","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BTAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193941736","title":"BioXcel Therapeutics宣布相关性研究取得积极结果，支持Serenity居家探索性疗效成果","url":"https://stock-news.laohu8.com/highlight/detail?id=1193941736","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193941736?lang=zh_cn&edition=full","pubTime":"2025-10-14 19:00","pubTimestamp":1760439629,"startTime":"0","endTime":"0","summary":"BioXcel Therapeutics宣布相关性研究取得积极结果，支持Serenity居家探索性疗效成果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BTAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518224141","title":"Bioxcel Therapeutics, Inc.盘中异动 大幅上涨5.34%报3.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518224141","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518224141?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:34","pubTimestamp":1741613647,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时34分，Bioxcel Therapeutics, Inc.股票出现异动，股价急速拉升5.34%。截至发稿，该股报3.55美元/股，成交量10.9296万股，换手率3.52%，振幅7.57%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2096.04%、413.43%、64.56%，振幅较大的相关个股有Akero Therapeutics, Inc.、Xencor, Inc.、Seer, Inc.，振幅分别为100.05%、99.13%、98.72%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021340796403690&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021340796403690&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BTAI","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2517165369","title":"Bioxcel Therapeutics, Inc.盘中异动 早盘股价大跌6.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517165369","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517165369?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:33","pubTimestamp":1741271605,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时33分，Bioxcel Therapeutics, Inc.股票出现异动，股价大幅下跌6.23%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.60%。其相关个股中，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为970.92%、111.73%、51.06%，振幅较大的相关个股有Plus Therapeutics, Inc.、Entero Therapeutics Inc.、Virax Biolabs Group Limited，振幅分别为24.20%、13.23%、12.51%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223325989eb49e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223325989eb49e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BTAI"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2517948552","title":"Bioxcel Therapeutics, Inc.盘中异动 早盘大幅拉升17.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517948552","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517948552?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:30","pubTimestamp":1741185045,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时30分，Bioxcel Therapeutics, Inc.股票出现波动，股价快速上涨17.96%。截至发稿，该股报3.19美元/股，成交量444.527万股，换手率143.31%，振幅0.56%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Zyversa Therapeutics, Inc.较为活跃，换手率分别为310.56%、251.30%、183.65%，振幅较大的相关个股有4D Molecular Therapeutics, Inc.、Plus Therapeutics, Inc.、Zura Bio Limited，振幅分别为8.56%、6.59%、5.61%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223045989d458b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223045989d458b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BTAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516734634","title":"Bioxcel Therapeutics, Inc.股价拉升12.49% 市值涨94.14万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516734634","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516734634?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:32","pubTimestamp":1741012337,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时32分，Bioxcel Therapeutics, Inc.股票出现波动，股价大幅拉升12.49%。截至发稿，该股报2.43美元/股，成交量33.3719万股，换手率10.76%，振幅3.34%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Entero Therapeutics Inc.、Alto Neuroscience, Inc.、Geovax Labs, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为47.32%、27.19%、22.55%，振幅较大的相关个股有Entero Therapeutics Inc.、Spruce Biosciences, Inc.、Cibus, Inc.，振幅分别为21.22%、19.25%、9.55%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223217abe63369&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223217abe63369&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BTAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514378557","title":"Bioxcel Therapeutics, Inc.股价拉升13.86% 市值涨84.68万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514378557","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514378557?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:31","pubTimestamp":1740753062,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时31分，Bioxcel Therapeutics, Inc.股票出现波动，股价快速拉升13.86%。截至发稿，该股报1.97美元/股，成交量1489.61万股，换手率480.24%，振幅1.14%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Anaptysbio, Inc.、Enveric Biosciences, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Virpax Pharmaceuticals, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为480.24%、239.11%、55.69%，振幅较大的相关个股有Trevi Therapeutics, Inc.、Enanta Pharmaceuticals, Inc.、Aardvark Therapeutics, Inc.，振幅分别为7.11%、6.58%、6.22%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223102abe0e9f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223102abe0e9f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BTAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513720455","title":"Bioxcel Therapeutics, Inc.盘中异动 早盘急速下挫5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720455","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513720455?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:55","pubTimestamp":1740408955,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时55分，Bioxcel Therapeutics, Inc.股票出现异动，股价大幅下挫5.16%。截至发稿，该股报2.02美元/股，成交量1.2261万股，换手率0.40%，振幅5.16%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Pepgen Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Telix Pharmaceutic涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为139.12%、56.79%、25.06%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、41.14%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225555abdb13e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225555abdb13e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BTAI","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513220290","title":"Bioxcel Therapeutics, Inc.盘中异动 临近午盘急速下挫5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513220290","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513220290?lang=zh_cn&edition=full","pubTime":"2025-02-22 00:47","pubTimestamp":1740156420,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日00时47分，Bioxcel Therapeutics, Inc.股票出现波动，股价快速跳水5.22%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。其相关个股中，Osr Holdings, Inc.、Nkgen Biotech, Inc.、Invivyd, Inc.涨幅较大，Nkgen Biotech, Inc.、Aditxt, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为228.03%、157.14%、121.91%，振幅较大的相关个股有Osr Holdings, Inc.、Osr Holdings Inc C/Wts 09/02/2028 、Nkgen Biotech, Inc.，振幅分别为72.46%、57.50%、48.35%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222004700a24ecdf8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222004700a24ecdf8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BTAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510863618","title":"Bioxcel Therapeutics, Inc.盘中异动 快速拉升13.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510863618","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510863618?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:32","pubTimestamp":1739197924,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时32分，Bioxcel Therapeutics, Inc.股票出现波动，股价急速上涨13.64%。截至发稿，该股报3.00美元/股，成交量1828股，换手率0.06%，振幅4.17%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Biodexa Pharmaceuticals Plc、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Ocean Biomedical, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为1497.30%、838.56%、553.24%，振幅较大的相关个股有Biodexa Pharmaceuticals Plc、Ocean Biomedical, Inc.、Nls Pharmaceutics Ltd.，振幅分别为12.53%、12.34%、7.48%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223204abc9a517&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223204abc9a517&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BTAI","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bioxceltherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.1053},{"period":"1month","weight":-0.3154},{"period":"3month","weight":-0.5024},{"period":"6month","weight":-0.6194},{"period":"1year","weight":-0.4365},{"period":"ytd","weight":-0.3625}],"compareEarnings":[{"period":"1week","weight":0.0412},{"period":"1month","weight":0.036},{"period":"3month","weight":-0.0111},{"period":"6month","weight":0.0315},{"period":"1year","weight":0.285},{"period":"ytd","weight":0.0061}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Bioxcel Therapeutics, Inc.于2017年3月29日成为特拉华州公司，为BioXcel的全资附属公司。该公司是一家利用人工智能平台开发神经科学领域变革性药物的生物制药公司。其商业产品IGALMI已获批用于治疗与精神分裂症和双相情感障碍相关的急性激越，其研发管线包括针对阿尔茨海默病激越的候选药物及免疫肿瘤学资产。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.080194},{"month":2,"riseRate":0.75,"avgChangeRate":0.207156},{"month":3,"riseRate":0.25,"avgChangeRate":-0.134633},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.049255},{"month":5,"riseRate":0.375,"avgChangeRate":-0.02476},{"month":6,"riseRate":0.5,"avgChangeRate":-0.047345},{"month":7,"riseRate":0.375,"avgChangeRate":-0.00598},{"month":8,"riseRate":0.25,"avgChangeRate":0.101973},{"month":9,"riseRate":0.25,"avgChangeRate":-0.149729},{"month":10,"riseRate":0.5,"avgChangeRate":-0.023255},{"month":11,"riseRate":0.375,"avgChangeRate":0.021118},{"month":12,"riseRate":0.375,"avgChangeRate":0.097907}],"exchange":"NASDAQ","name":"Bioxcel Therapeutics Inc.","nameEN":"Bioxcel Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Bioxcel Therapeutics Inc.(BTAI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Bioxcel Therapeutics Inc.(BTAI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Bioxcel Therapeutics Inc.,BTAI,Bioxcel Therapeutics Inc.股票,Bioxcel Therapeutics Inc.股票老虎,Bioxcel Therapeutics Inc.股票老虎国际,Bioxcel Therapeutics Inc.行情,Bioxcel Therapeutics Inc.股票行情,Bioxcel Therapeutics Inc.股价,Bioxcel Therapeutics Inc.股市,Bioxcel Therapeutics Inc.股票价格,Bioxcel Therapeutics Inc.股票交易,Bioxcel Therapeutics Inc.股票购买,Bioxcel Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Bioxcel Therapeutics Inc.(BTAI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Bioxcel Therapeutics Inc.(BTAI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}